Intellia Therapeutics Inc

NTLA•United States

Healthcare United States In Vitro & In Vivo Diagnostic SubstancesOptions Available

Need professional-grade analysis? Visit stockanalysis.com

$12.84

-2.80%

End of day

Market Cap

N/A

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	4.81	-0.50	0.52	—	1.25
Calmar	—	—	8.15	-0.61	0.53	—	2.06
Sharpe	—	—	2.96	-0.39	0.37	—	0.76
Omega	—	—	1.42	1.01	1.17	—	1.18
Martin	—	—	16.75	-0.81	0.97	—	4.32
Ulcer	—	—	14.73	53.76	39.14	—	37.91

Also Listed On

0JBU.LSE

London Stock Exchange · GBP

Intellia Therapeutics Inc (NTLA) Price Performance

Intellia Therapeutics Inc (NTLA) trades on United States in USD. The company is classified in the Healthcare sector under the In Vitro & In Vivo Diagnostic Substances industry. The stock currently trades at $12.84, down 2.80% from the previous close.

Over the past year, NTLA has traded between a low of $6.28 and a high of $27.98. The stock has gained 47.1% over this period. It is currently 54.1% below its 52-week high.

Company Info

Sector: Healthcare
Industry: In Vitro & In Vivo Diagnostic Substances
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): $57.88M
EBITDA: N/A
Profit Margin: -896.77%
EPS (TTM): N/A
Book Value: 871.96

Technical Indicators

52 Week High: $28.25
52 Week Low: $5.90
50 Day MA: $12.51
200 Day MA: $12.42
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: N/A